Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Huading Modern Biopharmaceutical is a specialized biopharmaceutical company based in China, focusing on the development and production of biochemical enzymes and recombinant proteins. The company is a significant manufacturer of thrombolytic agents such as Urokinase and Streptokinase, as well as Hyaluronidase for clinical use. With GMP-certified facilities, Huading provides high-purity active pharmaceutical ingredients (APIs) and finished drug products for cardiovascular and hematological applications. The firm maintains a strong presence in the domestic Chinese market while exporting its biological products globally. Their expertise lies in large-scale protein purification and biochemical extraction processes, positioning them as a key supplier in the biochemical drug sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 重庆市华鼎现代生物制药.